Emerging Proteins in CRPC: Functional Roles and Clinical Implications
Prostate cancer (PCa) is the most common cancer in men in the western world, but the lack of specific and sensitive markers often leads to overtreatment of prostate cancer which eventually develops into castration-resistant prostate cancer (CRPC). Novel protein markers for diagnosis and management o...
Main Authors: | Piaoping Kong, Lingyu Zhang, Zhengliang Zhang, Kangle Feng, Yiwen Sang, Xiuzhi Duan, Chunhua Liu, Tao Sun, Zhihua Tao, Weiwei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.873876/full |
Similar Items
-
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
by: Tomoyuki Makino, et al.
Published: (2021-04-01) -
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)
by: Taro Iguchi, et al.
Published: (2019-04-01) -
Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical Needs
by: Turco F, et al.
Published: (2022-09-01) -
Looking for a Simplified Diagnostic Model to Identify Potentially Lethal Cases of Prostate Cancer at Initial Diagnosis: An ImGO Pilot Study
by: Serena Macrini, et al.
Published: (2022-03-01) -
Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease
by: Bo-Ren Wang, et al.
Published: (2022-08-01)